Legend Biotech (LEGN)
(Real Time Quote from BATS)
$43.86 USD
-1.40 (-3.09%)
Updated Sep 25, 2024 12:42 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/18/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 90.74% |
ABR | 1.30 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.46 |
Next Year | -0.69 |
EPS (TTM) | -0.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 136.77M | 176.25M | 581.91M | 1.05B |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 148.53M | 214.53M | 638.91M | 1.22B |
Low Estimate | 124.43M | 159.95M | 512.70M | 920.00M |
Year ago Sales | 96.01M | 79.46M | 285.14M | 581.91M |
Year over Year Growth Est. | 42.46% | 121.81% | 104.08% | 80.11% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.47 | -1.46 | -0.69 |
# of Estimates | 8 | 8 | 9 | 8 |
Most Recent Consensus | -0.52 | -0.36 | -0.85 | 0.10 |
High Estimate | -0.44 | -0.26 | -0.85 | 0.58 |
Low Estimate | -0.76 | -0.75 | -2.18 | -1.63 |
Year ago EPS | -0.17 | -0.40 | -1.47 | -1.46 |
Year over Year Growth Est. | -241.18% | -17.50% | 0.68% | 53.05% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 4 | 7 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 4 | 3 | 1 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.47 | -1.46 | -0.69 |
7 Days Ago | -0.58 | -0.47 | -1.46 | -0.69 |
30 Days Ago | -0.58 | -0.47 | -1.56 | -0.69 |
60 Days Ago | -0.55 | -0.50 | -1.86 | -0.54 |
90 Days Ago | -0.55 | -0.49 | -1.85 | -0.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.58 | -0.47 | -0.85 | -0.69 |
Zacks Consensus Estimate | -0.58 | -0.47 | -1.46 | -0.69 |
Earnings ESP | 0.00% | 0.00% | 41.91% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -0.16 | -0.40 | -0.17 | NA |
Estimate | -0.54 | -0.29 | -0.70 | -0.56 | NA |
Difference | 0.49 | 0.13 | 0.30 | 0.39 | 0.33 |
Surprise | 90.74% | 44.83% | 42.86% | 69.64% | 62.02% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more